Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

taVNS in Infants Severe Dysphagia

NCT: NCT07802301 · NOT_YET_RECRUITING

NCT IDNCT07802301
StatusNOT_YET_RECRUITING
Start Date2026-08-30
Completion2027-03-31
SponsorMedical University of South Carolina (OTHER)
First posted
Last updated

Brief Summary

This study evaluates the safety, feasibility, and preliminary effects of transcutaneous auricular vagus nerve stimulation (taVNS) paired with an oral sensorimotor training protocol in infants with severe dysphagia. Infants with significant sucking and swallowing impairment will receive twice-daily taVNS paired with oromotor training over a three-week period. Outcomes include swallowing mechanics, sucking proficiency, and functional feeding performance assessed before and after the intervention.

Frequently Asked Questions

What is taVNS in Infants Severe Dysphagia?

taVNS in Infants Severe Dysphagia is a clinical trial registered under NCT07802301. Current status: NOT_YET_RECRUITING.

What is the status of NCT07802301?

The current status of NCT07802301 (taVNS in Infants Severe Dysphagia) is: NOT_YET_RECRUITING.

When did taVNS in Infants Severe Dysphagia start?

taVNS in Infants Severe Dysphagia started on 2026-08-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑